US patent application filed 14 August 2026 Technology · Pharma & MedTech

The first Agentic Commercial Execution Platform
for Pharma & MedTech.

Two engines in one: MC90² brainstorms strategic initiatives at scale, then breaks them down into compliance-filtered 90-day execution plans — per rep, per account. Full compliance, full audit, continuous learning.

Request a Demo Explore Pilot Collaboration

Early-stage · Product ready · First paying design partner

Live Demo

app.veraniqs.com/home

Good morning, Dana

W3 / 12

Live demo · sample data for a fictional customer. Click anything — switch tabs, filter accounts, run the brainstorm engine.

The reality we address

Commercial execution in Pharma & MedTech is breaking under its own complexity.

Across global commercial organizations, the same five symptoms keep surfacing — regardless of region, brand, or therapy area.

Execution Gaps

Strategy lives in slides. Execution drifts in the field.

Poor Prioritization

Reps optimize the visible, not the valuable.

Lack of Visibility

Management sees results, not the decisions that produced them.

Territory Stagnation

Underperforming territories stay underperforming, quarter after quarter.

Slow Decision-Making

By the time the signal reaches the decision-maker, the window has closed.

Where MC90 moves the needle

Five shifts that compound, quarter after quarter.

MC90 is built around measurable outcomes — not features. Every recommendation, every alert, every nudge is anchored to one of four business levers.

→

Initiatives → 90-Day Plans

Translate every business initiative into a concrete 90-day action plan — for every rep, every account, every channel.

⟳

Organizational Memory

MC90 remembers every account, every HCP, every rep, every decision. Nothing is lost when people change roles — the institutional knowledge stays.

↗

Continuous Learning

Every cycle, MC90 learns what worked — per customer, per rep, per context — and the next recommendation is sharper than the last.

◎

Management Visibility

A single source of truth across territories, brands, and markets — auditable end-to-end.

✦

Infinite Brainstorming

A creative partner that never tires. Explore endless angles on any commercial question — and turn the best ideas into structured, executable plans.

The MC90 framework

A proprietary decision intelligence engine — not a feature, a framework.

MC90² is a Patent-Pending Agentic Commercial Execution Platform purpose-built for Pharma & MedTech. Two engines in one — a Brainstorm Engine that generates strategic initiatives at infinite scale, and an Execution Engine that converts the winners into compliance-filtered 90-day plans, per rep, per account. Eleven specialized agents coordinate through a proprietary orchestration layer to produce auditable, compliance-safe, action-ready outputs.

Strategy Master

Long-term commercial strategy and portfolio direction.

Data & Account Analyst

Segment, account, and HCP-level insight.

Coach & Mentor

Field rep development and call quality improvement.

Coordinator

Orchestrates agents into a single coherent answer.

Problem Solver

Diagnoses commercial blockers and surfaces options.

Growth Marketer

Campaign, channel, and engagement optimization.

Digital Twin

Simulate decisions before they reach the field.

R&D

Future-proof innovation in a sandboxed environment.

Guardian

Proactive risk, churn, and compliance monitoring.

Performance & Insights

Closes the feedback loop — learns what worked, and why.

Competitor Scanner

Daily competitor scanning — maps threats and opportunities into MC90.

A glimpse inside

Role-based dashboards. One framework, three lenses.

MC90 delivers its output through dedicated dashboards — one for the rep, one for the manager, one for the executive. Each role sees the same underlying intelligence, framed for the decisions they actually own.

app.veraniqs.com / mc90 / commercial-cockpit

MC90

Commercial Cockpit

Today's Priorities

Territory Analytics

HCP Intelligence

Brand Performance

Field Coaching

Compliance Log

Good morning, Sarah

Your priorities — Week 23

Target Achievement

94%

+6.2% vs last week

High-Value HCPs

12 require action

Compliance Score

100%

EFPIA / EMA verified

TOP RECOMMENDATION

Re-engage Dr. M. Cohen (Cardiology · USA)

Last engagement 47 days ago. Recent prescription pattern shifted toward competitor brand (+18% Q/Q). Patient pool size and historical responsiveness make this the highest-yield call this week.

Score: 92 / 100

Confidence: High

Compliance: Approved

How it works

From scattered data to a single, defensible decision.

Initiative In

A business initiative comes in (launch, growth target, share defense). MC90 ingests CRM, IMS, internal data and field signals around it.

Analyze

15-component weighted scoring engine evaluates every account, HCP and channel against the initiative.

90-Day Plan Out

A concrete 90-day action plan — week by week, account by account — compliance-filtered, fully audit-trailed.

Role-Based Dashboards

Delivered to reps, managers and executives — each sees only what's relevant to their decisions.

Learn

Continuous feedback loop on real outcomes — every cycle sharpens the next plan.

Built-in discipline

Compliance and transparency are not features. They are the foundation.

◆

RAG-Only

Every recommendation cites its source. No hallucinations.

◈

EFPIA / EMA Filter

Regulatory compliance filter runs on every output.

◇

Full Audit Trail

Every recommendation is fully transparent and traceable.

◉

Human-in-the-Loop

The system drafts. The human reviews, edits, decides.

Why we exist

A name that carries a promise.

Vision

To reinvent how organizations make commercial decisions — with truth, intelligence, and discipline at the core.

Mission

Delivering the first Agentic Commercial Execution Platform to Pharma & MedTech commercial teams — where compliance and audit are non-negotiable.

Why "Veraniqs"?

The name encodes our promise: Ver from the Latin Veritas (truth) — every recommendation traceable to its source, every output auditable. IQ for intelligence — multi-agent AI tuned for the rigor pharma demands. Truth and intelligence, fused.

Who we are

Building the first Agentic Commercial Execution Platform for Pharma & MedTech.

Veraniqs is an early-stage company with a working product, already engaged with our first paying design partner and in active conversations with leading pharma and MedTech companies. We believe pharma commercial execution deserves the same rigor that pharma R&D already has.

Two engines in one. The Brainstorm Engine generates strategic commercial initiatives at infinite scale. The Execution Engine converts the winning initiatives into compliance-filtered 90-day plans — per rep, per account. Aktana recommends. We brainstorm and execute.

Our approach is to make AI invisible: the user works with simple, clear outputs — and the complexity sits underneath, doing the heavy lifting.

Specialized agents

Weighted components

Hallucinations tolerated

Provisional patent application filed 14 Aug 2026

Founder · Industry Insider

Ran Itshaki

Founder & CEO, Veraniqs

16+ years of enterprise commercial leadership in Pharma & MedTech. Built MC90 from the inside — by someone who has lived the operational gaps it solves.

Ecosystem & validation

Building on the strongest infrastructure partners in AI.

Veraniqs is selected for partner programs across the AI and cloud ecosystem — and operates under a US Provisional Patent.

Startup Program

Founders track · May 2026

Microsoft

for Startups

Azure infrastructure credits

NVIDIA

Developer Program

Active member

Google

for Startups Cloud Program

Start tier · May 2026

Anthropic

Console & API

Active integration

U.S. Patent &
Trademark Office

Provisional Patent

Filed August 2026

Program participation. Not a partnership endorsement.

Let's talk

A conversation, not a pitch.

We are selectively engaging with pharmaceutical leaders to explore where MC90 can add measurable value. A 30-minute introduction call — no commitments, just understanding.

ran@veraniqs.com

☎

Phone

+972-54-670-2034

⌬